Differential inhibition of secretagogue-stimulated sodium uptake in adrenal chromaffin cells by activation of D4 and D5 dopamine receptors.
Differential inhibition of secretagogue-stimulated sodium uptake in adrenal chromaffin cells by activation of D4 and D5 dopamine receptors.
复制标题
通过激活 D4 和 D5 多巴胺受体,差异性抑制肾上腺嗜铬细胞中促分泌剂刺激的钠摄取。
DOI:
10.1046/j.1471-4159.1996.67051960.x
复制
发表时间:
1996
影响因子:
4.7
通讯作者:
Senogles,SE
中科院分区:
文献类型:
--
作者:
Dahmer,MK;Senogles,SE
Recent studies have demonstrated that D1‐selective and D2‐selective dopamine receptor agonists inhibit catecholamine secretion and Ca2+uptake into bovine adrenal chromaffin cells by receptor subtypes that we have identified by PCR as D5, a member of the D1‐like dopamine receptor subfamily, and D4, a member of the D2‐like dopamine receptor subfamily. The purpose of this study was to determine whether activation of D5 or D4 receptors inhibits influx of Na+, which could explain inhibition of secretion and Ca2+uptake by dopamine agonists. D1‐selective agonists preferentially inhibited both dimethylphenylpiperazinium‐ (DMPP) and veratridine‐stimulated22Na+influx into chromaffin cells. The D1‐selective agonists chloro‐APB hydrobromide (CI‐APB; 100 µM) and SKF‐38393 (100 µM) inhibited DMPP‐stimulated Na+uptake by 87.5 ± 2.3 and 59.7 ± 4.5%, respectively, whereas the D2‐selective agonist bromocriptine (100 µM) inhibited Na+uptake by only 22.9 ± 5.0%. Veratridine‐stimulated Na+uptake was inhibited 95.1 ± 3.2 and 25.7 ± 4.7% by 100 µMCI‐APB or bromocriptine, respectively. The effect of CI‐APB was concentration dependent. A similar IC50(∼18 µM) for inhibition of both DMPP‐ and veratridine‐stimulated Na+uptake was obtained. The addition of 8‐bromo‐cyclic AMP (1 mM) had no effect on either DMPP‐ or veratridine‐stimulated Na+uptake. These observations suggest that D1‐selective agonists are inhibiting secretagogue‐stimulated Na+uptake in a cyclic AMP‐independent manner.